Analystreport

Magenta Therapeutics Inc (NASDAQ: MGTA) was downgraded by analysts at Goldman Sachs Group Inc from a "buy" rating to a "neutral" rating.

Magenta Therapeutics, Inc.  (MGTA) 
Last magenta therapeutics, inc. earnings: 11/13 08:00 am Check Earnings Report